Table 4.
Drop-out status | Group B 160 mg/d (n = 56) | Group C 250 mg/d (n = 54) | P-value2 |
Drop-outs without recurrence | 5 | 11 | 0.214 |
< 80% compliance | 3 (60.0) | 10 (90.9) | |
≥ 80% compliance | 2 (40.0) | 1 (9.1) | |
Non-withdrawal subjects | 51 | 43 | 0.171 |
< 80% compliance | 11 (21.6) | 15 (34.9) | |
≥ 80% compliance | 40 (78.4) | 28 (65.1) |
1≥ 80% compliance denotes received ≥ 80% of required doses (12 doses/cycle × 9 cycles × 80);
Fisher’s exact test.